硕迪生物 GPCR 深 沪
已收盘 07-02 16:00:00 美东时间
53.45
+1.330
+2.55%
华盛通- 最 高54.24
- 今 开51.43
- 成交量 59.25万股
- 最 低 51.0208
- 昨 收 52.12
- 总市值 37.99亿
- 52周最高 94.90
- 市盈率 静 --
- 换手率 0.83%
- 52周最低 15.80
- 委 比 -60.00%
- 总股本 7107.45万
- 历史最高 94.90
- 量 比 0.54
- 振 幅 6.18%
- 历史最低 13.22
- 每 手 1
- 风险率 20.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bioxyne Withdraws 90,833 Lapsed Performance Rights From Capital Structure
The latest announcement is out from Bioxyne Limited ( ($AU:BXN) ). Bioxyne Limi...
07-03 10:32
Sonim Technologies Strengthens Capital Structure With Preferred Financing
Sonim Technologies ( ($SONM) ) has provided an announcement. On June 29, 2026, ...
07-02 21:28
Easy Smart Group Details Board and Committee Structure
Easy Smart Group Holdings Limited ( ($HK:2442) ) has shared an update. Easy Sma...
07-02 21:08
Yuanda China Clarifies Board Composition and Governance Structure
The latest announcement is out from Yuanda China Holdings Ltd. ( ($HK:2789) ). ...
07-02 17:39
QXO Completes TopBuild Acquisition and Expands Capital Structure
QXO Inc ( ($QXO) ) just unveiled an update. QXO closed its acquisition of TopBu...
07-02 04:39
We Win Limited Certifies Full Compliance with SEBI Insider Trading Data Rules
We Win Ltd. ( ($IN:WEWIN) ) has provided an announcement. We Win Limited report...
07-01 14:54
Archer Aviation Shareholders Uphold Structure at Annual Meeting
Archer Aviation ( ($ACHR) ) has issued an announcement. At its 2026 Annual Meet...
07-01 05:25
XTL Completed the Acquisition of Psyga Bio Ltd.
XTL Biopharmaceuticals completes acquisition of Psyga Bio, becoming a dedicated psychedelic medicine company. The deal positions XTL with a clinical pipeline, GMP manufacturing facility, and IP library. Psyga Bio's products target severe mental health disorders. The acquisition was approved by regulators and supported by $1.5M in funding. The U.S. regulatory environment is favorable, with the FDA accelerating approvals for psychedelic treatments....
06-30 21:15
Parvis Invest amends concurrent financing to C$ 3 million unsecured convertible debenture offering
Parvis Invest amends concurrent financing to C$ 3 million unsecured convertible debenture offering Parvis Invest amended its concurrent financing into unsecured convertible debentures, targeting up to C$ 3 million in gross proceeds. Structure revised to include full warrants per debenture unit; boar
06-30 20:55
Hepsiburada Completes CEO Transition, Unveils Dual-Leadership Structure
D-Market ( ($HEPS) ) just unveiled an update. On June 30, 2026, Hepsiburada ann...
06-30 20:28
